Working with Diffine to help clients in biotechnology use artificial intelligence to extract more from their experiments using computer vision, machine learning, deep learning, and the latest data science.

Providing marketing, business development and corporate strategy services to technology companies.Recent projects include: • Negotiated multi-million dollar sale of scientific software package• Re-engineered a bioinformatics software and content company to focus on areas of core competency and greatest unmet market need. • Strategic review and market assessment for an under-performing software business unit. • Interim head of marketing for a scientific software organization.• Business plan, investor solicitation, and web site content development for high-tech startup.

Head of the Accelrys platform business, consisting of the Pipeline Pilot scientific operating platform. After the acquisition of SciTegic, I helped facilitate the integration and transition to the foundational platform for Accelrys’ future scientific operating system. Managed staff responsibile for marketing, business development, post-sales support, and pre-sales support.• Led the fastest growing division within the company, approaching 1/3 of the company's total business.• Helped to bring a customer-centric approach to Accelrys, contributing the highest customer satisfaction scores ever received.• Introduced new product for text analytics and image processing with external resources while ensuring the continued development of our core platform technology.• Concurrently served as interim head of life sciences teams for 6 months.

With oversight for both marketing and scientific support teams, I helped to drive this startup company to become the recognized industry leader in cheminformatics dataflow software. Playing multiple roles in this new company, I pursued business development, promotion, product specification, and corporate strategy.• Helped propel SciTegic from the creation of our first product to the established market leader and finally to a merger with a larger entity.• Established a strong corporate identity and successfully rolled out the product line, Pipeline Pilot, ultimately resulting is recurring sales over $15M per year.• Initiated, negotiated, and closed a multi-million dollar co-marketing and distribution alliance with the leading vendor in the industry. • Led the team to achieve the highest customer support satisfaction score (99.1%) ever seen by TNS Prognostics.

I established and managed a staff with worldwide responsibility for strategic planning, market research, product management, promotion, and technology licensing. I led marketing and product planning for the company’s strategic redirection from a flat government market into the explosive genomics industry, doubling our total revenue in one year. • Developed marketing from an ad-hoc function to a productive organization with product management, marketing communications and administrative personnel.• Executed a successful marketing campaign in support of new product roll-out, driving annual bioinformatics revenue from under $1M to over $5M.

I led the design and market introduction of innovative new software products for bioinformatics and sequence analysis. My responsibilities included: market research, business planning, product specification, strategic relationships, promotional literature, corporate presentations, and internal sales training. In addition, I was a member of the team that considered and promoted merger opportunities, ultimately resulting in the acquisition of MSI by Pharmacopeia. • Launched a new software product line, “WebLab Gene Explorer,” into a market area previously unfamiliar to the company.• Initiated three strategic alliances that enhanced our product offering through integration with complementary technology and joint marketing.

I directed a team of software consultants in the development of a high-end system for genome similarity searching. I contributed to the full cycle of product development, personally designing user interfaces and performing quality control. • Significantly reduced development time and saved vital programming resources by devising an alternate method of client-server communication.• Reduced system cost by 75% by developing a method to port our specialized parallel imple¬mentation onto general-purpose computers without a loss of performance.

I conceived of a new method for computer-aided cloning strategy optimization and co-founded GeneCraft. We developed Vector Director software for molecular biologists. In addition to starting and managing this new business, I designed, tested, and marketed the application. I ultimately sold the product to a distributor.